Chemo-radiotherapy in nasopharyngeal carcinoma at Ramathibodi Hospital, Bangkok.
Southeast Asian J Trop Med Public Health
;
1985 Dec; 16(4): 619-24
Article
in English
| IMSEAR
| ID: sea-33184
ABSTRACT
Combined chemotherapy (Cis-platinum and 5 FU) and radiation therapy were given to 11 patients with stage IV (except 1) nasopharyngeal carcinoma. None had distant metastasis. Mean duration of follow-up was 16.2 months. Objective response (CR+PR) at the primary lesion were 10 out of 11 (90.9%), while CR was 7 out of 11 (63.6%). CR+PR at the regional node were 10 out of 10 (100%), while CR was 9 out of 10 (90%). There has been no recurrence so far. One patient died of hepatocellular carcinoma. Side effects, mainly from radiation therapy, were clinically acceptable. One had transient cervical myelitis, which improved after medical treatment. There was no significant myelosuppression.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Thailand
/
Female
/
Humans
/
Male
/
Carcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Nasopharyngeal Neoplasms
/
Combined Modality Therapy
/
Herpesvirus 4, Human
/
Adult
Country/Region as subject:
Asia
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
1985
Type:
Article
Similar
MEDLINE
...
LILACS
LIS